Postprandial inflammation is considered to be pro-atherogenic. Vitamin D can reduce inflammation and arterial stiffness. We hypothesized that vitamin D3 improves postprandial arterial elasticity by the modulation of leukocyte activation. Healthy volunteers underwent two oral fat-loading tests (OFLTs). The augmentation index (AIx) and flow cytometric quantification of leukocyte activation markers were measured. After the first OFLT, 100 000 IU of vitamin D3 was administered and a second OFLT was carried out 7 days later. Six men and six women were included. A favorable reduction in AIx was found after vitamin D3 supplementation (P = 0.042) in both genders. After vitamin D3, exclusively in women a reduction in the area under the postprandial curve for monocytes CD11b and CD35 by 10.5% (P = 0.016) and 12.5% (P = 0.04) and neutrophil CD11b by 17.0% (P = 0.014) was observed. In conclusion, vitamin D3 probably increased postprandial arterial elasticity in men and women, but reduced postprandial leukocyte activation exclusively in women.
INTRODUCTION
Endothelial function and arterial elasticity can improve after vitamin D supplementation in vitamin D-deficient subjects.
1,2 The immunological effects of vitamin D may be the key link between vitamin D and cardiovascular disease, as inflammation is involved in the development of atherosclerosis. 3 As acute inflammatory changes as well as vascular dysfunction occur in the postprandial state, 4 the aim of the study was to investigate whether vitamin D3 can reduce leukocyte activation and improve arterial elasticity postprandially in men and women.
MATERIALS AND METHODS
Measurements were performed before and after vitamin D3 supplementation as a nonrandomized cross-over study in healthy men and women aged between 18 and 50 years. At baseline, arterial elasticity was determined by the augmentation index (AIx) at the radial artery according to standard operating procedures (Sphygmocor, AtCor Medical, Sydney, Australia). 5 A fasting venous blood sample was drawn and subjects received an oral fat-loading test (OFLT) using fresh cream in a dose of 50 g of fat per square meter body surface. The AIx was repeated at 2-h intervals until 8 h. The expression of CD11b, CD66b, CD35 and CD36 by monocytes and neutrophils was measured by flow cytometry at baseline and at 4 and 8 h postprandially as described previously. 6 At the end of the first OFLT participants received 100 000 IU of vitamin D3. The second OFLT was performed 7 days later.
Data are given as mean ± s.d. in the text and tables and as mean ± s.e.m. in the figures. Differences were tested using the paired Student's t-test or by Wilcoxon matched pairs signed ranks test where appropriate. The total area under the postprandial curve (AUC) was calculated with PRISM version 5.0 (Graph Pad Software, San Diego, CA, USA). All subjects gave written informed consent and the study was approved by the Regional Medical Ethical Committee Rotterdam, the Netherlands (EudraCT: 2010-024182-44).
RESULTS
Six men and six women were included. Besides significantly increased serum 25-hydroxyvitamin D3, no significant changes were observed in the fasting state after vitamin D3 supplementation (Supplementary Table 1 ). Postprandial lipemia was unaffected by vitamin D3. Integrin expression levels increased maximally at 4 h postprandially. In the fasting state, no changes in integrin expression for monocytes and neutrophils were observed after vitamin D3. In females, the AUC for the CD11b expression on monocytes and neutrophils and for CD35 expression on monocytes was significantly reduced together with a similar trend for the CD35 and CD66b expression on neutrophils and CD36 on monocytes, whereas no changes were observed in men. The AIx was reduced postprandially after vitamin D3, resulting in a significantly reduced AUC for AIx (107.5 ± 93.6%*h vs 88.7 ± 98.3% *h, P = 0.042) with similar trends in men and women seperately ( Figure 1 and Table 1) .
DISCUSSION
The present study shows that a single high dose of vitamin D3 reduced postprandial leukocyte activation in women, whereas the improvement in postprandial arterial elasticity was observed in both genders. Therefore, the improvement in postprandial arterial elasticity seen after vitamin D3 can probably not be mediated by changes in the inflammatory markers studied here.
In vitro 1,25-dihydroxyvitamin D3 reduces the monocyte CD11b expression and their phagocytic capacity. 7 Sex steroids may have influenced the vitamin D3 effects on leukocyte activation. Binding and cellular accumulation of 1,25-dihydroxyvitamin D3 is increased in women with subsequent decreased leukocyte activation suggesting a synergistic effect between 1,25-dihydroxyvitamin D3 and estradiol. 8, 9 The results may also have been influenced by the wide variation in 25-hydroxyvitamin D3 concentrations as the CD11b expression on monocytes decrease with increasing concentrations of 1,25-dihydroxyvitamin D3 in vitro.
7 A placebo-controlled randomized trial can address the current uncertainties associated with our cross-over study design. This study has been initiated in our department.
In conclusion, vitamin D3 increased postprandial arterial elasticity in men and women probably by a direct effect on the arterial wall. Vitamin D3 reduced postprandial leukocyte activation exclusively in women and therefore, could not fully explain the improved postprandial arterial elasticity. 
